Financials
- Market Capitalization 2.48 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1823 | VRDN Viridian Therapeutics, Inc. - Common Stock | 22.90 USD | -0.78% | -4.78% | +21.81% | +2.00% | 2.59 B USD | ||
| 1853 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.21 USD | -1.56% | -3.85% | +1.16% | -17.34% | 2.49 B USD | ||
| 1857 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.70 USD | -1.22% | -0.92% | +7.78% | +15.89% | 2.48 B USD | ||
| 1860 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 34.08 USD | -0.32% | +0.09% | +7.10% | +14.59% | 2.46 B USD |